Share Email Print
cover

Proceedings Paper

Er:YAG and Nd:YAG laser in treatment of patients with contraindications of conventional dental and maxillofacial surgery
Author(s): Roman Smucler; Jiri Mazanek
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

In clinical praxis we must treat patients with some relative or absolute contraindications every day. Need of hospitalization, antibiotics, hemostyptics and complex examinations makes dentoalveolar and maxillofacial surgery in those cases quite expensive. Combination of Nd:YAG and Er:YAG laser gives us new possibilities. We can help some untreatable patients or transfer care from hospital to dental office. We have been trying to solve contraindications for laser therapy five years. In the center of our work are disorders of blood coagulation, immunity and metabolism. Nd:YAG laser is very useful in coagulation and vaporization of dental gum hypertrophies, benign and malign tumors in case of chronic anticoagulation therapy and immunosupress / in combination for example- after heart transplantation /. Special chapter is the care of patients with disseminated tumors. Er:YAG laser large solve big lesions because of minimal invasivity of course but for small benign tumors are recidives is ideal. Better and quicker healing make new standard of patients' cooperation. Generally fashionable and more comfortable laser treatment minimize need of general anesthesia. After five years we use complex laser therapy in our routine. Aim of our new work is to find ideal combination of cutting lasers to minimize classical complications of laser surgery / carbonization, long and secondary healing /.

Paper Details

Date Published: 24 March 2000
PDF: 8 pages
Proc. SPIE 3910, Lasers in Dentistry VI, (24 March 2000); doi: 10.1117/12.380849
Show Author Affiliations
Roman Smucler, Charles Univ. Prague and ASKLEPION (Czech Republic)
Jiri Mazanek, Charles Univ. Prague (Czech Republic)


Published in SPIE Proceedings Vol. 3910:
Lasers in Dentistry VI
John D. B. Featherstone; Peter Rechmann; Daniel Fried, Editor(s)

© SPIE. Terms of Use
Back to Top